PTC Therapeutics Inc (PTCT) stock news · rev $1.73B
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
This PTCT news page leads with what PTC Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for PTCT yet. We will not pad this page with generic market recap.
Latest reported PTCT revenue for 2025-12-31 was $1.73B. Net income was $682.6M. Revenue was up 114.5% from 2024-12-31 to 2025-12-31. PTCT currently screens at market cap $6.51B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PTCT stock page; for the tape open the quote page.
PTCT stock news FAQ
What are PTCT's latest revenue and net income?
Latest cached PTC Therapeutics Inc (PTCT) revenue for Dec 31, 2025 was $1.73B. Net income was $682.6M. Statements: https://lician.com/financials/ptct
How did PTCT revenue change from the prior cached period?
Cached PTC Therapeutics Inc (PTCT) revenue was up 114.5% from $806.8M (Dec 31, 2024) to $1.73B (Dec 31, 2025). Statements: https://lician.com/financials/ptct
What is PTCT's market cap?
PTC Therapeutics Inc (PTCT) market cap is $6.51B on the latest cached fundamentals snapshot.
What kind of company is PTCT?
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Where is PTCT stock news listed?
Cached stock news for PTC Therapeutics Inc (PTCT) is listed at https://lician.com/news/ptct. Filings: https://lician.com/sec/ptct
Not investment advice.